| Amount | Holding |
|---|---|
| 5.87% | UnitedHealth Group Inc |
| 5.63% | Novartis AG |
| 5.54% | Roche Holding AG Dividend Right Cert. |
| 5.39% | Merck & Co Inc |
| 5.29% | Johnson & Johnson |
| 4.89% | AbbVie Inc |
| 4.31% | AstraZeneca PLC |
| 4.29% | Pfizer Inc |
| 3.41% | Eli Lilly and Co |
| 3.19% | Ascendis Pharma A/S ADR |
| 3.17% | Danaher Corp |
| 3.13% | Thermo Fisher Scientific Inc |
| 3.06% | Boston Scientific Corp |
| 2.87% | Vertex Pharmaceuticals Inc |
| 2.86% | Regeneron Pharmaceuticals Inc |
| 2.76% | Biogen Inc |
| 2.28% | Baxter International Inc |
| 2.24% | Abbott Laboratories |
| 2.21% | Cigna Corp |
| 2.17% | Intuitive Surgical Inc |
| 2.16% | Humana Inc |
| 1.85% | Gilead Sciences Inc |
| 1.69% | Amgen Inc |
| 1.66% | Lonza Group Ltd |
| 1.41% | McKesson Corp |
Expense Ratio Rating
1 /10
Expense Rating
0 /10
Market Score
7 /10
Category Score
0 /10
Market Size
7 /10
$PHSBX Alternatives
29%
FI Score
- phsbx
- Mutual Fund
- Sector Equity
- Healthcare
Putnam Global Health Care Fund Class B
Expenses: 1.84% (Better than 0% of similar funds)
This is a bad choice for a Healthcare Sector Equity fund. See why ยป